Very few randomized trials stratifying by genotype a priori. Hard to justify cost for patients w/o better data.
- Very few randomized trials stratifying by genotype a priori. Hard to justify cost for patients w/o better data.
Currently playing around with some data,genotypes are covariates in the model.effects are very model specific, few studies report >1 model